Trial Profile

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 04 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tirzepatide (Primary)
Indications Obesity
Focus Therapeutic Use
Acronyms GRABS-0

Most Recent Events

28 Oct 2024 Planned initiation date changed from 1 Oct 2024 to 1 Nov 2024.
07 Oct 2024 Status changed from not yet recruiting to recruiting.
11 Jun 2024 Phase changed from II/III to II. Primary endpoint 'Gastrointestinal symptoms' shifted to secondary endpoint.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com